Waterer G, Lord J, Hofmann T, Jouhikainen T, et al. A Phase I, dose-escalating study of safety and pharmacokinetics of inhaled dry
powder vancomycin (AeroVanc) in volunteers and patients with cystic fibrosis: a
new approach to therapy for methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2020 Jan 21. pii: AAC.01776.
PMID: 31964790